Penserra Capital Management LLC Sangamo Therapeutics, Inc Transaction History

Penserra Capital Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$0.58 - $1.47 $7,164 - $18,157	-12,352 Reduced 12.43%	87,000 $52,000
Q2 2023 Aug 11, 2023	BUY	$1.11 - $1.74 $68,422 - $107,257	61,642 Added 163.46%	99,352 $129,000
Q1 2023 Apr 24, 2023	BUY	$1.66 - $3.67 $3,469 - $7,670	2,090 Added 5.87%	37,710 $66,000
Q4 2022 Feb 13, 2023	SELL	$2.77 - $5.07 $22,871 - $41,862	-8,257 Reduced 18.82%	35,620 $111,000
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $135,909 - $203,387	31,829 Added 264.18%	43,877 $214,000
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $2,204 - $4,173	672 Added 5.91%	12,048 $49,000
Q1 2022 May 13, 2022	BUY	$5.23 - $7.82 $59,496 - $88,960	11,376 New	11,376 $66,000
Q4 2021 Feb 15, 2022	SELL	$7.29 - $10.97 $24,239 - $36,475	-3,325 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.01 - $12.01 $450 - $600	50 Added 1.53%	3,325 $29,000
Q2 2021 Aug 12, 2021	BUY	$10.17 - $12.64 $203 - $252	20 Added 0.61%	3,275 $39,000
Q1 2021 May 13, 2021	SELL	$10.88 - $17.05 $163 - $255	-15 Reduced 0.46%	3,255 $40,000
Q4 2020 Feb 12, 2021	BUY	$9.23 - $18.18 $19,069 - $37,559	2,066 Added 171.59%	3,270 $51,000
Q3 2020 Nov 13, 2020	BUY	$9.38 - $12.48 $11,293 - $15,025	1,204 New	1,204 $11,000

111

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $180M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.